Argenx
ARGX
#523
Rank
NZ$70.60 B
Marketcap
$1,162
Share price
-1.58%
Change (1 day)
85.21%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

We have found no dividend yield history for this company